Human Molecular Genetics Advance Access originally published online on June 15, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 16 1785-1791
DOI: 10.1093/hmg/ddh183
Human Molecular Genetics, Vol. 13, No. 16 © Oxford University Press 2004; all rights reserved
Rapid evolution of primate antiviral enzyme APOBEC3G
Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA
Received April 23, 2004; Accepted June 3, 2004
Human cytidine deaminase APOBEC3G and the virion infectivity factor (vif) of the human immunodeficiency virus (HIV) are a pair of antagonistic molecules. In the absence of vif, APOBEC3G induces a high rate of dC to dU mutations in the nascent reverse transcripts of HIV that leads to the degradation of the HIV genome. HIV vif, on the other hand, can suppress the translation and trigger the degradation of human APOBEC3G. Here, we studied the rate of APOBEC3G gene evolution from five hominoids and two Old World monkeys. Averaged across the entire coding region, the rate of non-synonymous nucleotide substitutions is 
1.4 times the rate of synonymous substitutions, strongly suggesting that APOBEC3G has been under positive Darwinian selection. A comparison between the nucleotide polymorphisms within humans and the substitutions among the seven primates reveals a significant excess of non-synonymous substitutions. Furthermore, the rate of charge-altering non-synonymous substitution is 1.8 times that of charge-conserving substitution, indicating that the selection is promoting the diversity of the protein charge profile. However, no difference in selective pressure on APOBEC3G is detected between hosts and non-hosts of HIV or simian immunodeficiency virus (SIV). These results, together with recent findings that the antiviral activity of APOBEC3G is not limited to HIV/SIV, suggest that the selective pressure on APOBEC3G is not solely from HIV/SIV and that APOBEC3G is a broad antiviral enzyme. The identification of pervasive positive selection for charge-altering amino acid substitutions supports the hypothesis of electrostatic interactions between APOBEC3G and vif or its functional equivalents.
* To whom correspondence should be addressed at: Department of Ecology and Evolutionary Biology, University of Michigan, 3003 Natural Science Building, 830 N. University Avenue, Ann Arbor, MI 48109, USA. Tel: +1 7347630527; Fax: +1 7347630544; Email: jianzhi{at}umich.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Henriet, G. Mercenne, S. Bernacchi, J.-C. Paillart, and R. Marquet Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors Microbiol. Mol. Biol. Rev., June 1, 2009; 73(2): 211 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. MacDuff, Z. L. Demorest, and R. S. Harris AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity Nucleic Acids Res., April 1, 2009; 37(6): 1854 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Chiu and W. C Greene APOBEC3G: an intracellular centurion Phil Trans R Soc B, March 12, 2009; 364(1517): 689 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Armitage, A. Katzourakis, T. de Oliveira, J. J. Welch, R. Belshaw, K. N. Bishop, B. Kramer, A. J. McMichael, A. Rambaut, and A. K. N. Iversen Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences J. Virol., September 1, 2008; 82(17): 8743 - 8761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Wiegand and B. R. Cullen Inhibition of Alpharetrovirus Replication by a Range of Human APOBEC3 Proteins J. Virol., December 15, 2007; 81(24): 13694 - 13699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jost, P. Turelli, B. Mangeat, U. Protzer, and D. Trono Induction of Antiviral Cytidine Deaminases Does Not Explain the Inhibition of Hepatitis B Virus Replication by Interferons J. Virol., October 1, 2007; 81(19): 10588 - 10596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Jonsson, G. Hache, M. D. Stenglein, S. C. Fahrenkrug, V. Andresdottir, and R. S. Harris Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins Nucleic Acids Res., November 14, 2006; 34(19): 5683 - 5694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Chiu, H. E. Witkowska, S. C. Hall, M. Santiago, V. B. Soros, C. Esnault, T. Heidmann, and W. C. Greene High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition PNAS, October 17, 2006; 103(42): 15588 - 15593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Heeney, A. G. Dalgleish, and R. A. Weiss Origins of HIV and the evolution of resistance to AIDS. Science, July 28, 2006; 313(5786): 462 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Bogerd, H. L. Wiegand, A. E. Hulme, J. L. Garcia-Perez, K. S. O'Shea, J. V. Moran, and B. R. Cullen Cellular inhibitors of long interspersed element 1 and Alu retrotransposition PNAS, June 6, 2006; 103(23): 8780 - 8785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Chiu and W. C. Greene APOBEC3 Cytidine Deaminases: Distinct Antiviral Actions along the Retroviral Life Cycle J. Biol. Chem., March 31, 2006; 281(13): 8309 - 8312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Cullen Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors J. Virol., February 1, 2006; 80(3): 1067 - 1076. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Podlaha, D. M. Webb, P. K. Tucker, and J. Zhang Positive Selection for Indel Substitutions in the Rodent Sperm Protein Catsper1 Mol. Biol. Evol., September 1, 2005; 22(9): 1845 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Schumacher, D. V. Nissley, and R. S. Harris APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast PNAS, July 12, 2005; 102(28): 9854 - 9859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-A. Langlois, R. C. L. Beale, S. G. Conticello, and M. S. Neuberger Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities Nucleic Acids Res., April 4, 2005; 33(6): 1913 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hache, M. T. Liddament, and R. S. Harris The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain J. Biol. Chem., March 25, 2005; 280(12): 10920 - 10924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Sawyer, L. I. Wu, M. Emerman, and H. S. Malik Positive selection of primate TRIM5{alpha} identifies a critical species-specific retroviral restriction domain PNAS, February 22, 2005; 102(8): 2832 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Turelli and D. Trono Editing at the Crossroad of Innate and Adaptive Immunity Science, February 18, 2005; 307(5712): 1061 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N. R. Landau APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication J. Biol. Chem., December 17, 2004; 279(51): 53379 - 53386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Vallender and B. T. Lahn Positive selection on the human genome Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R245 - R254. [Abstract] [Full Text] [PDF]
|
|